Effects of Atorvastatin on Myonecrosis

NCT00344019 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

97

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Coronary Disease

Interventions

DRUG: Placebo Oral Tablet
DRUG: Atorvastatin 80mg
OTHER: Screening

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]